NewsMarkets

Business

Judge Denies Novo Nordisk Bid to Block Eli Lilly Weight-Loss Drug Ads

A US judge rejected Novo Nordisk's request to halt Eli Lilly's advertising campaign, ruling the company failed to demonstrate irreparable harm.

2 publishers · 2 articles · first seen 27 Oct 2026 · updated 2h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

2 publishers have covered this in 2 articles since 27 Oct 2026. Quartz published first, on 27 October at 11:30 UTC; STAT followed 1h 56m later. The most recent article, from STAT, appeared on 27 October at 13:25 UTC.

Outlets reporting it: Quartz, STAT.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more STAT
  2. Judge denied Novo Nordisk bid to block Eli Lilly weight-loss drug ads Quartz

In this story

  • Novo Nordisk
  • Eli Lilly
  • Zahid Quraishi
Embed this story

Paste this into any web page to show the live odds, with a link back here.